首页 > 最新文献

中华内科杂志最新文献

英文 中文
[Expert consensus on imaging evaluation of early endovascular treatment of acute ischemic stroke]. 【急性缺血性脑卒中早期血管内治疗的影像学评价专家共识】。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20241231-00868

Endovascular treatment has become the primary treatment for patients with acute ischemic stroke (AIS) due to large vessel occlusion. Its development and clinical application have expanded significantly in recent years. Imaging assessment plays a pivotal role in guiding both preoperative screening and postoperative management in AIS patients undergoing such interventions. However, updated expert consensus and standardized guidelines remain lacking. To address this gap, the Professional Committee of Interventional Neurology of the Chinese Research Hospital Association convened leading cerebrovascular disease experts to formulate consensus recommendations based on domestic clinical practice, aiming to provide authoritative guidance for imaging evaluation in this patient population.

血管内治疗已成为急性缺血性脑卒中(AIS)大血管闭塞患者的主要治疗方法。近年来,它的开发和临床应用有了显著的扩展。影像学评估在AIS患者进行此类干预的术前筛查和术后管理中发挥着关键作用。然而,最新的专家共识和标准化指南仍然缺乏。为了弥补这一空白,中国研究型医院协会介入神经学专业委员会召集国内领先的脑血管病专家,结合国内临床实践,制定共识建议,旨在为这一患者群体的影像学评估提供权威指导。
{"title":"[Expert consensus on imaging evaluation of early endovascular treatment of acute ischemic stroke].","authors":"","doi":"10.3760/cma.j.cn112138-20241231-00868","DOIUrl":"10.3760/cma.j.cn112138-20241231-00868","url":null,"abstract":"<p><p>Endovascular treatment has become the primary treatment for patients with acute ischemic stroke (AIS) due to large vessel occlusion. Its development and clinical application have expanded significantly in recent years. Imaging assessment plays a pivotal role in guiding both preoperative screening and postoperative management in AIS patients undergoing such interventions. However, updated expert consensus and standardized guidelines remain lacking. To address this gap, the Professional Committee of Interventional Neurology of the Chinese Research Hospital Association convened leading cerebrovascular disease experts to formulate consensus recommendations based on domestic clinical practice, aiming to provide authoritative guidance for imaging evaluation in this patient population.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"723-735"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert consensus on combination therapies of oral anti-diabetic drugs for adults with type 2 diabetes (2025 edition)]. 【成人2型糖尿病口服降糖药联合治疗专家共识(2025年版)】。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20250515-00279

Combination therapies involving oral anti-diabetic agents with complementary mechanisms of action are widely employed in the clinical management of type 2 diabetes mellitus (T2DM). Initiating combination therapy early-either at diagnosis or through timely escalation from monotherapy-can expedite achievement of individualized glycemic targets and slow disease progression in newly diagnosed patients. The inclusion of agents with weight-reducing properties is particularly beneficial for overweight or obese individuals, as it enhances insulin sensitivity and facilitates glycemic control. Moreover, selecting combinations with proven cardiovascular and renal benefits offers long-term organ protection and improves overall prognosis. This consensus statement provides guidance on the optimal use of oral combination therapies for effective and individualized management of T2DM in clinical practice.

2型糖尿病(T2DM)的临床治疗广泛采用口服降糖药和互补作用机制的联合治疗。早期开始联合治疗,无论是在诊断时还是在单药治疗的基础上及时升级,都可以加速实现个体化血糖目标,减缓新诊断患者的疾病进展。含有具有减肥特性的药物对超重或肥胖个体特别有益,因为它可以增强胰岛素敏感性并促进血糖控制。此外,选择已证实对心血管和肾脏有益的联合用药可提供长期的器官保护并改善整体预后。本共识声明为临床实践中有效和个性化管理2型糖尿病的口服联合治疗的最佳使用提供了指导。
{"title":"[Expert consensus on combination therapies of oral anti-diabetic drugs for adults with type 2 diabetes (2025 edition)].","authors":"","doi":"10.3760/cma.j.cn112138-20250515-00279","DOIUrl":"10.3760/cma.j.cn112138-20250515-00279","url":null,"abstract":"<p><p>Combination therapies involving oral anti-diabetic agents with complementary mechanisms of action are widely employed in the clinical management of type 2 diabetes mellitus (T2DM). Initiating combination therapy early-either at diagnosis or through timely escalation from monotherapy-can expedite achievement of individualized glycemic targets and slow disease progression in newly diagnosed patients. The inclusion of agents with weight-reducing properties is particularly beneficial for overweight or obese individuals, as it enhances insulin sensitivity and facilitates glycemic control. Moreover, selecting combinations with proven cardiovascular and renal benefits offers long-term organ protection and improves overall prognosis. This consensus statement provides guidance on the optimal use of oral combination therapies for effective and individualized management of T2DM in clinical practice.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"707-722"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation of information quality in autoimmune liver disease-related videos on TikTok]. [TikTok自身免疫性肝病相关视频信息质量评价]。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20241101-00722
Y Q Fang, G Jia, Y S Liu, L N Cui, Y L Shang, Y Han

Objective: To evaluate the quality of information on autoimmune liver disease in videos on the TikTok short video platform. Methods: The keyword "autoimmune liver disease" was used to search the top 200 videos on TikTok in the default sorting order. Using the DISCERN video quality assessment tool and the structured content integrity evaluation tool, we assessed the quality of the information in each video in relation to the pertinent disease guidelines. Furthermore, we investigated any relationships between the quality of the videos and their characteristics (likes, comments, retweets, days and duration of uploading). Results: A total of 140 videos were included, 96.4% of which were provided by medical professionals. The content completeness scores for each dimension were as follows: definition, 1.0 (0.0, 1.0); symptoms, 0.0 (0.0, 1.0); risk factors, 0.0 (0.0, 0.5); assessment, 0.5 (0.0, 1.5); management, 0.5 (0.0, 1.0); and outcome, 0.0 (0.0, 1.0). Furthermore, 91.4% of videos with DISCERN scores of ≤50 were of "fair" quality or below. Additionally, the difference in DISCERN scores between videos from different publishers was not statistically significant (P>0.05). The number of likes, comments, favorites, retweets, and video duration had a strong positive correlation with the overall DISCERN score (r=0.17, 0.18, 0.25, 0.26, 0.44, all P<0.05). Conclusions: The overall quality of videos related to autoimmune liver disease on the TikTok video platform is low. Therefore, publishers should focus on the comprehensiveness and accuracy of the information. Additionally, the TikTok platform should optimize its video review mechanism to provide the public with more accurate and reliable health information.

目的:评价TikTok短视频平台视频中自身免疫性肝病信息的质量。方法:以“自身免疫性肝病”为关键词,按默认排序顺序搜索TikTok视频top 200。使用DISCERN视频质量评估工具和结构化内容完整性评估工具,我们评估了每个视频中与相关疾病指南相关的信息质量。此外,我们还调查了视频质量与其特征(点赞、评论、转发、上传天数和持续时间)之间的关系。结果:共纳入视频140份,其中96.4%由医学专业人员提供。各维度的内容完整性得分如下:定义,1.0 (0.0,1.0);症状,0.0 (0.0,1.0);危险因素,0.0 (0.0,0.5);评估,0.5 (0.0,1.5);管理,0.5 (0.0,1.0);结果是0.0(0.0,1.0)。此外,在DISCERN分数≤50的视频中,91.4%的视频质量为“一般”或更低。此外,不同出版商的视频在DISCERN分数上的差异无统计学意义(P>0.05)。点赞数、评论数、收藏数、转发数和视频时长与DISCERN总分呈强正相关(r=0.17、0.18、0.25、0.26、0.44,均为p)。结论:TikTok视频平台上与自身免疫性肝病相关的视频整体质量较低。因此,出版商应注重信息的全面性和准确性。此外,TikTok平台应优化视频审核机制,为公众提供更准确、更可靠的健康信息。
{"title":"[Evaluation of information quality in autoimmune liver disease-related videos on TikTok].","authors":"Y Q Fang, G Jia, Y S Liu, L N Cui, Y L Shang, Y Han","doi":"10.3760/cma.j.cn112138-20241101-00722","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20241101-00722","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the quality of information on autoimmune liver disease in videos on the TikTok short video platform. <b>Methods:</b> The keyword \"autoimmune liver disease\" was used to search the top 200 videos on TikTok in the default sorting order. Using the DISCERN video quality assessment tool and the structured content integrity evaluation tool, we assessed the quality of the information in each video in relation to the pertinent disease guidelines. Furthermore, we investigated any relationships between the quality of the videos and their characteristics (likes, comments, retweets, days and duration of uploading). <b>Results:</b> A total of 140 videos were included, 96.4% of which were provided by medical professionals. The content completeness scores for each dimension were as follows: definition, 1.0 (0.0, 1.0); symptoms, 0.0 (0.0, 1.0); risk factors, 0.0 (0.0, 0.5); assessment, 0.5 (0.0, 1.5); management, 0.5 (0.0, 1.0); and outcome, 0.0 (0.0, 1.0). Furthermore, 91.4% of videos with DISCERN scores of ≤50 were of \"fair\" quality or below. Additionally, the difference in DISCERN scores between videos from different publishers was not statistically significant (<i>P></i>0.05). The number of likes, comments, favorites, retweets, and video duration had a strong positive correlation with the overall DISCERN score (<i>r</i>=0.17, 0.18, 0.25, 0.26, 0.44, all <i>P</i><0.05). <b>Conclusions:</b> The overall quality of videos related to autoimmune liver disease on the TikTok video platform is low. Therefore, publishers should focus on the comprehensiveness and accuracy of the information. Additionally, the TikTok platform should optimize its video review mechanism to provide the public with more accurate and reliable health information.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"759-765"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of continuous glucose monitoring in diabetes screening and glycemic optimization]. [连续血糖监测在糖尿病筛查和血糖优化中的作用]。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20250401-00192
Y P Wang, J Wang, Y M Mu
{"title":"[The role of continuous glucose monitoring in diabetes screening and glycemic optimization].","authors":"Y P Wang, J Wang, Y M Mu","doi":"10.3760/cma.j.cn112138-20250401-00192","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20250401-00192","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"701-706"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical features of ulcerative colitis in patients with small intestinal bacterial overgrowth]. 【溃疡性结肠炎伴小肠细菌过度生长的临床特点】。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20241129-00787
L R Chen, C Y Li, D Wang, Q Liu, X N Liang, Y Yao, Y X Luo, J Song, Q Li, X L Zhang

Objective: To explore the relationship between intestinal bacterial overgrowth (SIBO) and ulcerative colitis (UC). Methods: From December 2023 to June 2024, 85 patients with UC from the Gastroenterology Department of the Luquan branch of the Second Hospital of Hebei Medical University were enrolled. The lactulose hydrogen-methane breath test was performed to assess the prevalence of SIBO. Clinical data, including basic information, clinical manifestations, endoscopic manifestations, inflammatory indicators, current medication regimen, and past medical history, were collected. Furthermore, the body mass index (BMI), modified Mayo score, and patient-reported outcome (PRO2) score were calculated to evaluate disease activity in each patient. The Student's t-test, Chi-square test, non-parametric test, and multiple logistic regression were used to analyze the data and explore the relationship between SIBO and UC. Results: The incidence of abdominal pain and bloating in patients who were SIBO positive with UC was higher than in those who were SIBO negative [abdominal pain: 50.0%(10/20) vs. 23.1%(15/65), χ²=5.34, P=0.021; abdominal distension: 40.0% (8/20) vs. 13.8% (9/65), χ²=5.01, P=0.025]; the difference was statistically significant (P<0.05). Patients who were SIBO positive with UC were more likely to develop hypoproteinemia and anemia than those who were SIBO negative [hypoproteinemia: 50.0% (10/20) vs. 15.4% (10/65), χ²=8.35, P=0.004; anemia: 35.0% (7/20) vs. 9.2% (6/65), χ²=5.98, P=0.014]; the difference was statistically significant (P<0.05). In the intestinal methanogen overgrowth (IMO) positive group, the number of patients with UC with 1-2 stool times/day was higher, and the distribution of stool times between the IMO positive and IMO negative groups was significantly different (χ2=6.45, P=0.040). Furthermore, combined hypoproteinemia and anemia were risk factors for SIBO in patients with UC (hypoproteinemia OR=4.331, 95%CI 1.117-16.799, P=0.034; anemia OR=5.515, 95%CI 1.231-24.700, P=0.026). Conclusions: We observed a clinical overlap between SIBO and UC. SIBO could be targeted to optimize the treatment of patients with UC in the future.

目的:探讨肠道细菌过度生长(SIBO)与溃疡性结肠炎(UC)的关系。方法:选取河北医科大学第二医院鹿泉分院消化内科于2023年12月至2024年6月收治的85例UC患者。采用乳果糖氢甲烷呼气试验评估SIBO的患病率。收集临床资料,包括基本信息、临床表现、内镜表现、炎症指标、目前用药方案、既往病史。此外,计算身体质量指数(BMI)、改良Mayo评分和患者报告的预后(PRO2)评分,以评估每位患者的疾病活动性。采用Student’st检验、卡方检验、非参数检验、多元logistic回归等方法对数据进行分析,探讨SIBO与UC之间的关系。结果:SIBO阳性合并UC患者的腹痛和腹胀发生率高于SIBO阴性患者[腹痛:50.0%(10/20)比23.1%(15/65),χ²=5.34,P=0.021;腹胀:40.0%(8/20)和13.8%(9/65),χ²= 5.01,P = 0.025);差异有统计学意义(P0.05)。SIBO阳性合并UC患者发生低蛋白血症和贫血的可能性高于SIBO阴性患者[低蛋白血症:50.0%(10/20)比15.4% (10/65),χ²=8.35,P=0.004;贫血:35.0%(7/20)和9.2%(6/65),χ²= 5.98,P = 0.014);差异有统计学意义(Pχ2=6.45, P=0.040)。此外,合并低蛋白血症和贫血是UC患者SIBO发生的危险因素(低蛋白血症OR= 4.3331, 95%CI 1.117-16.799, P=0.034;OR=5.515, 95%CI 1.231 ~ 24.700, P=0.026)。结论:我们观察到SIBO和UC的临床重叠。SIBO可作为未来优化UC患者治疗的靶标。
{"title":"[Clinical features of ulcerative colitis in patients with small intestinal bacterial overgrowth].","authors":"L R Chen, C Y Li, D Wang, Q Liu, X N Liang, Y Yao, Y X Luo, J Song, Q Li, X L Zhang","doi":"10.3760/cma.j.cn112138-20241129-00787","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20241129-00787","url":null,"abstract":"<p><p><b>Objective:</b> To explore the relationship between intestinal bacterial overgrowth (SIBO) and ulcerative colitis (UC). <b>Methods:</b> From December 2023 to June 2024, 85 patients with UC from the Gastroenterology Department of the Luquan branch of the Second Hospital of Hebei Medical University were enrolled. The lactulose hydrogen-methane breath test was performed to assess the prevalence of SIBO. Clinical data, including basic information, clinical manifestations, endoscopic manifestations, inflammatory indicators, current medication regimen, and past medical history, were collected. Furthermore, the body mass index (BMI), modified Mayo score, and patient-reported outcome (PRO2) score were calculated to evaluate disease activity in each patient. The Student's <i>t</i>-test, Chi-square test, non-parametric test, and multiple logistic regression were used to analyze the data and explore the relationship between SIBO and UC. <b>Results:</b> The incidence of abdominal pain and bloating in patients who were SIBO positive with UC was higher than in those who were SIBO negative [abdominal pain: 50.0%(10/20) vs. 23.1%(15/65), <i>χ</i>²=5.34, <i>P</i>=0.021; abdominal distension: 40.0% (8/20) vs. 13.8% (9/65), <i>χ</i>²=5.01, <i>P</i>=0.025]; the difference was statistically significant (<i>P<</i>0.05). Patients who were SIBO positive with UC were more likely to develop hypoproteinemia and anemia than those who were SIBO negative [hypoproteinemia: 50.0% (10/20) vs. 15.4% (10/65), <i>χ</i>²=8.35, <i>P</i>=0.004; anemia: 35.0% (7/20) vs. 9.2% (6/65), <i>χ</i>²=5.98, <i>P</i>=0.014]; the difference was statistically significant (<i>P</i><0.05). In the intestinal methanogen overgrowth (IMO) positive group, the number of patients with UC with 1-2 stool times/day was higher, and the distribution of stool times between the IMO positive and IMO negative groups was significantly different (<i>χ</i><sup>2</sup>=6.45, <i>P=</i>0.040). Furthermore, combined hypoproteinemia and anemia were risk factors for SIBO in patients with UC (hypoproteinemia <i>OR=</i>4.331, 95%<i>CI</i> 1.117-16.799, <i>P</i>=0.034; anemia <i>OR</i>=5.515, 95%<i>CI</i> 1.231-24.700, <i>P</i>=0.026). <b>Conclusions:</b> We observed a clinical overlap between SIBO and UC. SIBO could be targeted to optimize the treatment of patients with UC in the future.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"753-758"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interaction between gender and visceral adiposity index-associated risk of type 2 diabetes]. [性别与2型糖尿病内脏脂肪指数相关风险的相互作用]。
Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn112138-20250115-00040
H Z Liu, X L Zhang, S Dong, X J Li, X M Fu, Y H Wang, X D Hu, B Li, Z H Lyu

Objective: To examine the interaction between gender and the visceral adiposity index (VAI) in relation to the risk of type 2 diabetes mellitus (T2DM). Methods: This retrospective cohort study utilized data from the public Dryad database derived from the NAGALA (NAFLD in the Gifu Area, Longitudinal Analysis) project (1994-2016). Participants were stratified into quartiles based on VAI levels. A multivariate Cox proportional hazards regression model was employed to evaluate whether VAI independently predicts T2DM risk. Kaplan-Meier survival curves and receiver operating characteristic (ROC) curves were constructed for each VAI quartile. Subgroup analyses were conducted to examine associations across age and body mass index categories. Both multiplicative and additive interaction effects between gender and VAI were assessed. Additionally, gender-specific Cox models were fitted to further explore these associations. Results: A total of 15 453 participants [8 419 males and 7 034 females; mean age, (43.7±8.9) years] were included, with a median follow-up duration of 5.39 years. During follow-up, 373 participants (2.4%) developed T2DM. After adjustment for potential confounders, higher VAI levels were independently associated with increased T2DM risk (HR=1.16; 95%CI 1.11-1.21), consistent with the results across VAI quartiles. Kaplan-Meier analysis revealed a significant trend of increasing T2DM incidence across VAI quartiles (P<0.001). The area under the ROC curve for VAI in predicting T2DM at 3, 5, and 10 years was 0.755, 0.735, and 0.696, respectively. Sensitivity analyses showed that elevated VAI was associated with increased T2DM risk across all age and body mass index subgroups (all P<0.05). Regarding interaction analysis, the HR (95%CI) for the multiplicative interaction between VAI and gender was 1.22 (1.19-1.26). The relative excess risk of interaction was -1.08 (95%CI -2.96 to -0.06), the attributable proportion of interaction was -0.54 (95%CI -1.35 to -0.01), and the synergy index was 0.48 (95%CI 0.26-0.91), indicating a negative additive interaction. Using low-VAI women as the reference group, the risk of T2DM in high-VAI women was higher (HR=2.53, 95%CI 1.59-4.02) compared to high-VAI men (HR=2.01, 95%CI 1.49-2.72). In gender-specific analyses, increasing VAI remained significantly associated with elevated T2DM risk after adjustment in both females (HR=1.43, 95%CI 1.21-1.68) and males (HR=1.16; 95%CI 1.11-1.22), with consistent findings across VAI quartiles. Conclusions: VAI and gender demonstrated multiplicative and additive interaction in relation to T2DM risk. The association between increasing VAI and T2DM risk was more pronounced in women than in men.

目的:探讨性别和内脏脂肪指数(VAI)与2型糖尿病(T2DM)发病风险的相互作用。方法:本回顾性队列研究利用了来自NAGALA(岐阜县NAFLD,纵向分析)项目(1994-2016)的公共Dryad数据库的数据。根据VAI水平将参与者分成四分位数。采用多变量Cox比例风险回归模型评价VAI是否能独立预测T2DM风险。对每个VAI四分位数构建Kaplan-Meier生存曲线和受试者工作特征(ROC)曲线。进行亚组分析以检查年龄和身体质量指数类别之间的关联。评估了性别与VAI之间的乘法和加性相互作用效应。此外,采用性别特异性Cox模型进一步探讨这些关联。结果:共纳入15 453人,其中男性8 419人,女性7 034人;平均年龄(43.7±8.9)岁),中位随访时间5.39年。在随访期间,373名参与者(2.4%)发展为T2DM。在对潜在混杂因素进行调整后,较高的VAI水平与T2DM风险增加独立相关(HR=1.16;95%CI 1.11-1.21),与VAI四分位数的结果一致。Kaplan-Meier分析显示,在VAI四分位数中,T2DM发病率有显著增加的趋势(VAI和性别之间乘法交互作用的PPHR (95%CI)为1.22(1.19-1.26)。相互作用的相对过量风险为-1.08 (95%CI -2.96 ~ -0.06),相互作用的归因比例为-0.54 (95%CI -1.35 ~ -0.01),协同作用指数为0.48 (95%CI 0.26 ~ 0.91),为负加性相互作用。以低vai女性为参照组,与高vai男性相比,高vai女性患T2DM的风险更高(HR=2.53, 95%CI 1.59-4.02) (HR=2.01, 95%CI 1.49-2.72)。在性别分析中,女性(HR=1.43, 95%CI 1.21-1.68)和男性(HR=1.16;95%CI 1.11-1.22),在VAI四分位数中有一致的发现。结论:VAI和性别表现出与T2DM风险相关的乘法和加法相互作用。VAI升高与2型糖尿病风险之间的关联在女性中比在男性中更为明显。
{"title":"[Interaction between gender and visceral adiposity index-associated risk of type 2 diabetes].","authors":"H Z Liu, X L Zhang, S Dong, X J Li, X M Fu, Y H Wang, X D Hu, B Li, Z H Lyu","doi":"10.3760/cma.j.cn112138-20250115-00040","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20250115-00040","url":null,"abstract":"<p><p><b>Objective:</b> To examine the interaction between gender and the visceral adiposity index (VAI) in relation to the risk of type 2 diabetes mellitus (T2DM). <b>Methods:</b> This retrospective cohort study utilized data from the public Dryad database derived from the NAGALA (NAFLD in the Gifu Area, Longitudinal Analysis) project (1994-2016). Participants were stratified into quartiles based on VAI levels. A multivariate Cox proportional hazards regression model was employed to evaluate whether VAI independently predicts T2DM risk. Kaplan-Meier survival curves and receiver operating characteristic (ROC) curves were constructed for each VAI quartile. Subgroup analyses were conducted to examine associations across age and body mass index categories. Both multiplicative and additive interaction effects between gender and VAI were assessed. Additionally, gender-specific Cox models were fitted to further explore these associations. <b>Results:</b> A total of 15 453 participants [8 419 males and 7 034 females; mean age, (43.7±8.9) years] were included, with a median follow-up duration of 5.39 years. During follow-up, 373 participants (2.4%) developed T2DM. After adjustment for potential confounders, higher VAI levels were independently associated with increased T2DM risk (<i>HR</i>=1.16; 95%<i>CI</i> 1.11-1.21), consistent with the results across VAI quartiles. Kaplan-Meier analysis revealed a significant trend of increasing T2DM incidence across VAI quartiles (<i>P</i><0.001). The area under the ROC curve for VAI in predicting T2DM at 3, 5, and 10 years was 0.755, 0.735, and 0.696, respectively. Sensitivity analyses showed that elevated VAI was associated with increased T2DM risk across all age and body mass index subgroups (all <i>P</i><0.05). Regarding interaction analysis, the <i>HR</i> (95%<i>CI</i>) for the multiplicative interaction between VAI and gender was 1.22 (1.19-1.26). The relative excess risk of interaction was -1.08 (95%<i>CI</i> -2.96 to -0.06), the attributable proportion of interaction was -0.54 (95%<i>CI</i> -1.35 to -0.01), and the synergy index was 0.48 (95%<i>CI</i> 0.26-0.91), indicating a negative additive interaction. Using low-VAI women as the reference group, the risk of T2DM in high-VAI women was higher (<i>HR</i>=2.53, 95%<i>CI</i> 1.59-4.02) compared to high-VAI men (<i>HR</i>=2.01, 95%<i>CI</i> 1.49-2.72). In gender-specific analyses, increasing VAI remained significantly associated with elevated T2DM risk after adjustment in both females (<i>HR=</i>1.43, 95%<i>CI</i> 1.21-1.68) and males (<i>HR</i>=1.16; 95%<i>CI</i> 1.11-1.22), with consistent findings across VAI quartiles. <b>Conclusions:</b> VAI and gender demonstrated multiplicative and additive interaction in relation to T2DM risk. The association between increasing VAI and T2DM risk was more pronounced in women than in men.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 8","pages":"736-744"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Heat shock protein family A member 5 regulation of ferroptosis alleviates acute-phase mucosal injury in ulcerative colitis]. [热休克蛋白家族A成员5调节铁下垂减轻溃疡性结肠炎急性期黏膜损伤]。
Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn112138-20240924-00601
J X Yan, X Y Bai, H Liang, F R Zhang, Y L Miao, J K Niu
<p><p><b>Objective:</b> This study aimed to investigate the role of heat shock protein family A member 5 (HSPA5) in ferroptosis at its regulatory mechanisms in ulcerative colitis (UC), using both a dextran sulfate sodium (DSS)-induced mouse model of acute colitis and in vitro cell experiments. <b>Methods:</b> Differentially expressed genes in UC were identified using the GSE87466 dataset from the Gene Expression Omnibus, cross-referenced with the ferroptosis-related gene database FerrDB (version 2). A protein-protein interaction (PPI) network was constructed, identifying HSPA5 as a core hub gene. To validate its role in vivo, acute colitis was induced in C57BL/6 mice using DSS, followed by treatment with the ferroptosis inhibitor Ferrostatin-1 (Fer-1). Lipid peroxidation and ferroptosis levels were assessed by measuring malondialdehyde (MDA) and iron content in colon tissues. The expression of ferroptosis-related proteins, including prostaglandin-endoperoxide synthase 2 (PTGS2), glutathione peroxidase 4 (GPX4), ferritin light chain (FTL), activating transcription factor 4 (ATF4), and HSPA5, in addition to tight junction proteins ZO-1 and Occludin, were evaluated using immunohistochemistry and Western blotting. In vitro, an inflammatory model was established using lipopolysaccharide (LPS)-stimulated Caco-2 cells. Lentiviral knockdown of HSPA5 was performed to assess its regulatory effects on ferroptosis by assessing MDA levels, GPX4 activity, and the expression of related proteins. Statistical analyses were conducted with SPSS (version 29.1), with <i>t</i>-tests or one-way ANOVA for normally distributed data and the Mann-Whitney <i>U</i> test for ordinal data. Statistical significance was set at <i>P</i><0.05. <b>Results:</b> Based on the PPI analysis and previous research, HSPA5 emerged as a key gene linking UC and ferroptosis. In DSS-treated mice, colonic injury was accompanied by elevated MDA levels (<i>t</i>=5.72, <i>P</i><0.001) and iron accumulation (<i>t</i>=6.32, <i>P</i><0.001). DSS also increased the expression of PTGS2 and proteins in the ATF4-HSPA5 pathway, while reducing the levels of GPX4, FTL, ZO-1, and Occludin. These findings could be partially reversed by Fer-1 (MDA: <i>t</i>=2.92, <i>P</i><0.05; iron: <i>t</i>=5.84, <i>P</i><0.001). In Caco-2 cells, LPS treatment elevated the expression of PTGS2, ATF4, and HSPA5, and elevated the MDA content (<i>t</i>=9.63, <i>P</i><0.001), while reducing the expression of FTL, GPX4, ZO-1, and Occludin, as well as GPX4 enzyme activity (<i>t</i>=-11.20, <i>P</i><0.001). Knockdown of HSPA5 further exacerbated these changes, significantly increasing MDA levels (<i>t</i>=4.15, <i>P</i><0.01), decreasing GPX4 activity (<i>t</i>=-9.81, <i>P</i><0.001), and altering ferroptosis-related protein expression. <b>Conclusion:</b> HSPA5 appears to protect against intestinal damage in UC by enhancing GPX4 expression and activity, thereby reducing ferroptosis and preserving epithelial barrier integrity through
目的:通过葡聚糖硫酸钠(DSS)诱导的急性结肠炎小鼠模型和体外细胞实验,探讨热休克蛋白家族A成员5 (HSPA5)在溃疡性结肠炎(UC)中铁下沉的调控机制。方法:使用来自基因表达Omnibus的GSE87466数据集鉴定UC中差异表达的基因,并与铁凋亡相关基因数据库FerrDB (version 2)交叉参考。构建蛋白相互作用(PPI)网络,确定HSPA5为核心枢纽基因。为了验证其在体内的作用,用DSS诱导C57BL/6小鼠急性结肠炎,然后用铁下沉抑制剂铁抑素-1 (fer1)治疗。通过测定结肠组织中丙二醛(MDA)和铁含量来评估脂质过氧化和铁下垂水平。采用免疫组织化学和Western blotting检测凋亡相关蛋白的表达,包括前列腺素内过氧化物合成酶2 (PTGS2)、谷胱甘肽过氧化物酶4 (GPX4)、铁蛋白轻链(FTL)、激活转录因子4 (ATF4)和HSPA5,以及紧密连接蛋白ZO-1和Occludin。体外用脂多糖(LPS)刺激Caco-2细胞建立炎症模型。慢病毒敲除HSPA5,通过评估MDA水平、GPX4活性和相关蛋白的表达来评估其对铁下垂的调节作用。统计学分析采用SPSS(29.1版),正态分布数据采用t检验或单因素方差分析,有序数据采用Mann-Whitney U检验。结果:基于PPI分析和既往研究,HSPA5成为UC与铁下垂的关键基因。在dss处理的小鼠中,结肠损伤伴随着MDA水平升高(t=5.72, Pt=6.32, Pt=2.92, Pt=5.84, Pt=9.63, Pt=-11.20, Pt=4.15, Pt=-9.81, p)。结论:HSPA5似乎通过增强GPX4的表达和活性来保护UC肠道损伤,从而减少铁凋亡,并通过维持紧密连接蛋白来保持上皮屏障的完整性。
{"title":"[Heat shock protein family A member 5 regulation of ferroptosis alleviates acute-phase mucosal injury in ulcerative colitis].","authors":"J X Yan, X Y Bai, H Liang, F R Zhang, Y L Miao, J K Niu","doi":"10.3760/cma.j.cn112138-20240924-00601","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20240924-00601","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; This study aimed to investigate the role of heat shock protein family A member 5 (HSPA5) in ferroptosis at its regulatory mechanisms in ulcerative colitis (UC), using both a dextran sulfate sodium (DSS)-induced mouse model of acute colitis and in vitro cell experiments. &lt;b&gt;Methods:&lt;/b&gt; Differentially expressed genes in UC were identified using the GSE87466 dataset from the Gene Expression Omnibus, cross-referenced with the ferroptosis-related gene database FerrDB (version 2). A protein-protein interaction (PPI) network was constructed, identifying HSPA5 as a core hub gene. To validate its role in vivo, acute colitis was induced in C57BL/6 mice using DSS, followed by treatment with the ferroptosis inhibitor Ferrostatin-1 (Fer-1). Lipid peroxidation and ferroptosis levels were assessed by measuring malondialdehyde (MDA) and iron content in colon tissues. The expression of ferroptosis-related proteins, including prostaglandin-endoperoxide synthase 2 (PTGS2), glutathione peroxidase 4 (GPX4), ferritin light chain (FTL), activating transcription factor 4 (ATF4), and HSPA5, in addition to tight junction proteins ZO-1 and Occludin, were evaluated using immunohistochemistry and Western blotting. In vitro, an inflammatory model was established using lipopolysaccharide (LPS)-stimulated Caco-2 cells. Lentiviral knockdown of HSPA5 was performed to assess its regulatory effects on ferroptosis by assessing MDA levels, GPX4 activity, and the expression of related proteins. Statistical analyses were conducted with SPSS (version 29.1), with &lt;i&gt;t&lt;/i&gt;-tests or one-way ANOVA for normally distributed data and the Mann-Whitney &lt;i&gt;U&lt;/i&gt; test for ordinal data. Statistical significance was set at &lt;i&gt;P&lt;/i&gt;&lt;0.05. &lt;b&gt;Results:&lt;/b&gt; Based on the PPI analysis and previous research, HSPA5 emerged as a key gene linking UC and ferroptosis. In DSS-treated mice, colonic injury was accompanied by elevated MDA levels (&lt;i&gt;t&lt;/i&gt;=5.72, &lt;i&gt;P&lt;/i&gt;&lt;0.001) and iron accumulation (&lt;i&gt;t&lt;/i&gt;=6.32, &lt;i&gt;P&lt;/i&gt;&lt;0.001). DSS also increased the expression of PTGS2 and proteins in the ATF4-HSPA5 pathway, while reducing the levels of GPX4, FTL, ZO-1, and Occludin. These findings could be partially reversed by Fer-1 (MDA: &lt;i&gt;t&lt;/i&gt;=2.92, &lt;i&gt;P&lt;/i&gt;&lt;0.05; iron: &lt;i&gt;t&lt;/i&gt;=5.84, &lt;i&gt;P&lt;/i&gt;&lt;0.001). In Caco-2 cells, LPS treatment elevated the expression of PTGS2, ATF4, and HSPA5, and elevated the MDA content (&lt;i&gt;t&lt;/i&gt;=9.63, &lt;i&gt;P&lt;/i&gt;&lt;0.001), while reducing the expression of FTL, GPX4, ZO-1, and Occludin, as well as GPX4 enzyme activity (&lt;i&gt;t&lt;/i&gt;=-11.20, &lt;i&gt;P&lt;/i&gt;&lt;0.001). Knockdown of HSPA5 further exacerbated these changes, significantly increasing MDA levels (&lt;i&gt;t&lt;/i&gt;=4.15, &lt;i&gt;P&lt;/i&gt;&lt;0.01), decreasing GPX4 activity (&lt;i&gt;t&lt;/i&gt;=-9.81, &lt;i&gt;P&lt;/i&gt;&lt;0.001), and altering ferroptosis-related protein expression. &lt;b&gt;Conclusion:&lt;/b&gt; HSPA5 appears to protect against intestinal damage in UC by enhancing GPX4 expression and activity, thereby reducing ferroptosis and preserving epithelial barrier integrity through ","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 7","pages":"643-651"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[National guidelines for the integrated management of obesity in primary care (2025)]. [国家初级保健肥胖症综合管理指南(2025年)]。
Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn112138-20250422-00231

Obesity is a significant public health problem in China. The development of a proactive and effective model to combat the obesity epidemic could alleviate the disease burden, improve population health, and ultimately support the achievement of the Healthy China goals. Obesity research has made significant progress domestically and internationally, resulting in continuous improvements in basic public health services within primary care. Therefore, the National Office of Basic Public Health Service Program for Primary Diabetes Care has organized experts to issue the National Guidelines for the Integrated Management of Obesity in Primary Care (2025). The aim of this guide is to assist primary care physicians with evidence-based recommendations for diagnosing and evaluating obesity, promoting standardized and integrated management for patients with obesity. It includes essential guidelines for patient management, an overview of obesity, diagnostic and evaluation criteria, integrated management strategies, and protocols for follow-up and referral.

在中国,肥胖是一个严重的公共卫生问题。制定积极有效的应对肥胖流行的模式,可以减轻疾病负担,改善人口健康,最终支持健康中国目标的实现。肥胖研究在国内和国际上取得了重大进展,导致初级保健中的基本公共卫生服务不断改善。因此,国家糖尿病初级保健基本公共卫生服务规划办公室组织专家发布了《国家初级保健肥胖综合管理指南(2025)》。本指南的目的是协助初级保健医生提供基于证据的肥胖诊断和评估建议,促进肥胖患者的标准化和综合管理。它包括患者管理的基本指南、肥胖概述、诊断和评估标准、综合管理策略以及随访和转诊协议。
{"title":"[National guidelines for the integrated management of obesity in primary care (2025)].","authors":"","doi":"10.3760/cma.j.cn112138-20250422-00231","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20250422-00231","url":null,"abstract":"<p><p>Obesity is a significant public health problem in China. The development of a proactive and effective model to combat the obesity epidemic could alleviate the disease burden, improve population health, and ultimately support the achievement of the Healthy China goals. Obesity research has made significant progress domestically and internationally, resulting in continuous improvements in basic public health services within primary care. Therefore, the National Office of Basic Public Health Service Program for Primary Diabetes Care has organized experts to issue the National Guidelines for the Integrated Management of Obesity in Primary Care (2025). The aim of this guide is to assist primary care physicians with evidence-based recommendations for diagnosing and evaluating obesity, promoting standardized and integrated management for patients with obesity. It includes essential guidelines for patient management, an overview of obesity, diagnostic and evaluation criteria, integrated management strategies, and protocols for follow-up and referral.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 7","pages":"604-613"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of gastrointestinal tract symptoms and related factors in patients with Parkinson's disease]. 【帕金森病患者胃肠道症状及相关因素分析】。
Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn112138-20241121-00773
X Y Cheng, S Qian, X L Lou, J Y Jin, J R Zhang, C J Mao, C F Liu
<p><p><b>Objective:</b> To observe the characteristics of gastrointestinal tract symptoms in patients with Parkinson's disease (PD) and analyze the characteristics of these symptoms in patients with different PD subtypes. <b>Methods:</b> A total of 297 PD patients who were admitted to the Neurology Department of the Second Affiliated Hospital of Soochow University from November 2022 to March 2024 were enrolled. The gastrointestinal symptoms of PD patients were evaluated using Drooling Severity and Frequency Scale (DSFS), Sialorrhea Clinical Scale for Parkinson's disease (SCS-PD), Drooling Rating Scale (DRS), Eating Assessment Tool 10 (EAT-10), Gastroparesis Cardinal Symptom Index (GCSI), and Rome Ⅳ diagnostic criteria. The patients were grouped based on the presence or absence of gastrointestinal symptoms. Additionally, they were stratified according to disease duration (≤2 years, 2-5 years, 5-10 years, and>10 years) and motor symptom subtype [tremor-dominant (TD) vs. postural instability and gait difficulty (PIGD)]. One-way ANOVA and logistic regression analysis were applied to examine between-group differences while Spearman correlation analysis was employed to assess correlations between clinical symptoms. <b>Results:</b> The average age of the patients with PD was 67.0 (60.0, 72.0) years, and 161 (54.2%) were male. The incidence of PD combined with gastrointestinal symptoms was, in descending order: constipation (191, 64.3%), salivation (155, 52.2%), gastroparesis (93, 31.3%), and dysphagia (68, 22.9%). Compared with PD patients without gastrointestinal symptoms, those with symptoms had higher scores in the RBD-HK [12.0 (5.0, 21.5) vs. 5.0 (0.0, 9.0), <i>Z=</i>-3.74, <i>P=</i>0.017], ESS [6.0 (2.0, 12.0) vs. 3.0 (0.0, 6.0), <i>Z</i>=-3.20, <i>P</i>=0.023], and MDS-UPDRS Part Ⅰ [9.0 (5.0, 14.0) vs. 5.0 (2.3, 9.0), <i>Z</i>=-3.61, <i>P</i>=0.014]. The severity of sialorrhea and deglutition disorders, along with the incidence of constipation, all increased with longer disease duration. Patients with the PIGD subtype had higher GCSI scores than those with the TD subtype [0.0 (0.0, 1.9) vs. 0.0 (0.0, 0.0), <i>Z</i>=-3.57, <i>P</i>=0.007]. Across the cohort, sialorrhea, deglutition disorders, gastroparesis, and constipation were positively associated with the H-Y stage, MDS-UPDRS Ⅰ, HAMD, NMSQ, and SCOPA-AUT; EAT-10 scores were negatively correlated with MoCA (<i>r</i>=-0.171, <i>P<</i>0.05); and GCSI scores were negatively correlated with MMSE and MoCA (<i>r</i>=-0.154, <i>r</i>=-0.169, both <i>P</i><0.05). <b>Conclusions:</b> Overall, 84.5% of the patients with PD had one or more gastrointestinal symptoms, and the incidence and severity of gastrointestinal symptoms increased with disease duration. The severity of gastroparesis was higher in the PIGD group than in the TD group. The scores of all gastrointestinal symptoms were positively correlated with the H-Y stage and MDS-UPDRS Ⅰ, while the GCSI scores were negatively correlated with the cogniti
目的:观察帕金森病(PD)患者胃肠道症状的特点,分析不同PD亚型患者胃肠道症状的特点。方法:选取2022年11月至2024年3月苏州大学第二附属医院神经内科住院的PD患者297例。采用流口水严重程度和频率量表(DSFS)、帕金森病唾液临床量表(SCS-PD)、流口水评定量表(DRS)、进食评估工具10 (EAT-10)、胃轻瘫主要症状指数(GCSI)和RomeⅣ诊断标准对PD患者的胃肠道症状进行评估。患者根据有无胃肠道症状进行分组。此外,根据病程(≤2年、2-5年、5-10年和bbb10年)和运动症状亚型[震颤显性(TD) vs姿势不稳定和步态困难(PIGD)]对患者进行分层。组间差异采用单因素方差分析和logistic回归分析,临床症状间相关性采用Spearman相关分析。结果:PD患者平均年龄67.0岁(60.0岁,72.0岁),男性161例(54.2%)。PD合并胃肠道症状的发生率由高到低依次为便秘(191例,64.3%)、流涎(155例,52.2%)、胃轻瘫(93例,31.3%)、吞咽困难(68例,22.9%)。与无胃肠道症状的PD患者相比,有症状的PD患者在RBD-HK评分[12.0 (5.0,21.5)vs. 5.0 (0.0, 9.0), Z=-3.74, P=0.017], ESS评分[6.0 (2.0,12.0)vs. 3.0 (0.0, 6.0), Z=-3.20, P=0.023]和MDS-UPDRS部分Ⅰ评分[9.0 (5.0,14.0)vs. 5.0 (2.3, 9.0), Z=-3.61, P=0.014]中得分较高。唾液和吞咽障碍的严重程度,以及便秘的发生率,都随着病程的延长而增加。PIGD亚型患者的GCSI评分高于TD亚型患者[0.0(0.0,1.9)比0.0 (0.0,0.0),Z=-3.57, P=0.007]。在整个队列中,唾液、吞咽障碍、胃轻瘫和便秘与H-Y期、MDS-UPDRSⅠ、HAMD、NMSQ和SCOPA-AUT呈正相关;EAT-10评分与MoCA呈负相关(r=-0.171, P0.05);GCSI评分与MMSE和MoCA呈负相关(r=-0.154, r=-0.169),均为p。结论:总体而言,84.5%的PD患者存在一种或多种胃肠道症状,且胃肠道症状的发生率和严重程度随病程的延长而增加。PIGD组胃轻瘫的严重程度高于TD组。所有胃肠道症状评分与H-Y分期和MDS-UPDRSⅠ呈正相关,而GCSI评分与认知评分呈负相关。
{"title":"[Analysis of gastrointestinal tract symptoms and related factors in patients with Parkinson's disease].","authors":"X Y Cheng, S Qian, X L Lou, J Y Jin, J R Zhang, C J Mao, C F Liu","doi":"10.3760/cma.j.cn112138-20241121-00773","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20241121-00773","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objective:&lt;/b&gt; To observe the characteristics of gastrointestinal tract symptoms in patients with Parkinson's disease (PD) and analyze the characteristics of these symptoms in patients with different PD subtypes. &lt;b&gt;Methods:&lt;/b&gt; A total of 297 PD patients who were admitted to the Neurology Department of the Second Affiliated Hospital of Soochow University from November 2022 to March 2024 were enrolled. The gastrointestinal symptoms of PD patients were evaluated using Drooling Severity and Frequency Scale (DSFS), Sialorrhea Clinical Scale for Parkinson's disease (SCS-PD), Drooling Rating Scale (DRS), Eating Assessment Tool 10 (EAT-10), Gastroparesis Cardinal Symptom Index (GCSI), and Rome Ⅳ diagnostic criteria. The patients were grouped based on the presence or absence of gastrointestinal symptoms. Additionally, they were stratified according to disease duration (≤2 years, 2-5 years, 5-10 years, and&gt;10 years) and motor symptom subtype [tremor-dominant (TD) vs. postural instability and gait difficulty (PIGD)]. One-way ANOVA and logistic regression analysis were applied to examine between-group differences while Spearman correlation analysis was employed to assess correlations between clinical symptoms. &lt;b&gt;Results:&lt;/b&gt; The average age of the patients with PD was 67.0 (60.0, 72.0) years, and 161 (54.2%) were male. The incidence of PD combined with gastrointestinal symptoms was, in descending order: constipation (191, 64.3%), salivation (155, 52.2%), gastroparesis (93, 31.3%), and dysphagia (68, 22.9%). Compared with PD patients without gastrointestinal symptoms, those with symptoms had higher scores in the RBD-HK [12.0 (5.0, 21.5) vs. 5.0 (0.0, 9.0), &lt;i&gt;Z=&lt;/i&gt;-3.74, &lt;i&gt;P=&lt;/i&gt;0.017], ESS [6.0 (2.0, 12.0) vs. 3.0 (0.0, 6.0), &lt;i&gt;Z&lt;/i&gt;=-3.20, &lt;i&gt;P&lt;/i&gt;=0.023], and MDS-UPDRS Part Ⅰ [9.0 (5.0, 14.0) vs. 5.0 (2.3, 9.0), &lt;i&gt;Z&lt;/i&gt;=-3.61, &lt;i&gt;P&lt;/i&gt;=0.014]. The severity of sialorrhea and deglutition disorders, along with the incidence of constipation, all increased with longer disease duration. Patients with the PIGD subtype had higher GCSI scores than those with the TD subtype [0.0 (0.0, 1.9) vs. 0.0 (0.0, 0.0), &lt;i&gt;Z&lt;/i&gt;=-3.57, &lt;i&gt;P&lt;/i&gt;=0.007]. Across the cohort, sialorrhea, deglutition disorders, gastroparesis, and constipation were positively associated with the H-Y stage, MDS-UPDRS Ⅰ, HAMD, NMSQ, and SCOPA-AUT; EAT-10 scores were negatively correlated with MoCA (&lt;i&gt;r&lt;/i&gt;=-0.171, &lt;i&gt;P&lt;&lt;/i&gt;0.05); and GCSI scores were negatively correlated with MMSE and MoCA (&lt;i&gt;r&lt;/i&gt;=-0.154, &lt;i&gt;r&lt;/i&gt;=-0.169, both &lt;i&gt;P&lt;/i&gt;&lt;0.05). &lt;b&gt;Conclusions:&lt;/b&gt; Overall, 84.5% of the patients with PD had one or more gastrointestinal symptoms, and the incidence and severity of gastrointestinal symptoms increased with disease duration. The severity of gastroparesis was higher in the PIGD group than in the TD group. The scores of all gastrointestinal symptoms were positively correlated with the H-Y stage and MDS-UPDRS Ⅰ, while the GCSI scores were negatively correlated with the cogniti","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 7","pages":"635-642"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Immunomodulatory effects and research progresses of budesonide enteric-coated capsules in IgA nephropathy]. 布地奈德肠溶胶囊对IgA肾病的免疫调节作用及研究进展。
Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn112138-20250403-00198
Q L Chen, J C Lyu
{"title":"[Immunomodulatory effects and research progresses of budesonide enteric-coated capsules in IgA nephropathy].","authors":"Q L Chen, J C Lyu","doi":"10.3760/cma.j.cn112138-20250403-00198","DOIUrl":"https://doi.org/10.3760/cma.j.cn112138-20250403-00198","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 7","pages":"688-692"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华内科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1